Ledger.Open graph →
SEC Form D · filed August 8, 2022

Carmot Therapeutics Inc

Offering
$160.7M
Sold
$160.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BERKELEY, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Peter K. Svennilson · Berkeley, CADirectorAetna Wun K. Trombley · Berkeley, CADirectorStig K. Hansen · Berkeley, CAExec · DirectorTim K. Kutzkey · Berkeley, CADirectorNoah R. Greenhill · San Francisco, CADirectorIris M. Wu · San Francisco, CADirectorJessica M. Woolf · San Francisco, CAExec · DirectorTimothy K. Garnett · Berkeley, CADirectorJoseph C. Lawler · CHICAGO, ILDirectorNeil Rose · BAINBRIDGE ISLAND, WADirectorDinkar A. Jetley · NEW YORK, NYExec · DirectorTim K. Kutzkey · Berkeley, CADirectorTimothy K. Garnett · Berkeley, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗